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ABSTRACT
The human thrombopoietin (THPO) gene displays a
series of alternative splicing events that provide
valuable models for studying splicing mechanisms.
The THPO region spanning exon 1–4 presents both
alternative splicing of exon 2 and partial intron
2 (IVS2) retention following the activation of a
cryptic 30 splice site 85 nt upstream of the authentic
acceptor site. IVS2 is particularly rich in stretches of
3–5 guanosines (namely, G1–G10) and we have
characterized the role of these elements in the
processing of this intron. In vivo studies show that
runs G7–G10 work in a combinatorial way to control
the selection of the proper 30 splice site. In particu-
lar, the G7 element behaves as the splicing hub of
intron 2 and its interaction with hnRNP H1 is critical
for the splicing process. Removal of hnRNP H1 by
RNA interference promoted the usage of the cryptic
30 splice site so providing functional evidence that
this factor is involved in the selection of the
authentic 30 splice site of THPO IVS2.
INTRODUCTION
Several studies have shown that exonic and intronic
sequences in addition to the well-conserved donor and accep-
tor sites may play a role in nuclear pre-mRNA splicing (1).
One of these motifs consists in runs of Gs placed within
introns immediately downstream of 50 splice sites as well
as upstream of 30 splice sites (2–4). Functional studies have
supported the hypothesis that small introns contain intronic
cis-acting elements based on G runs that drive efﬁcient selec-
tion of particular splice sites. The relevance of G-rich
sequences in the control of splicing has been shown in
many studies dealing with constitutive and alternative splic-
ing both in physiological (5–8) and pathological (9–13)
events. Investigations on the trans-acting factors potentially
involved in splicing models carrying intronic G runs have
identiﬁed at least one main factor, hnRNP H, as one of the
proteins that bind to G-rich sequences (11,13,14) and can
regulate splicing of different genes with variable effects
(8,13). These studies have also proposed that mechanisms
of splicing control by G runs can be further regulated by
the interplay with different sequences and by the recruitment
of other factors (8,13). Therefore, it is of interest to character-
ize the mechanism of action of G runs-dependent splicing
modulation in different models in order to establish if they
function through the same biochemical language and their
possible link with physiological or pathological events.
Human thrombopoietin (THPO) stimulates the prolifera-
tion and maturation of megakaryocytes and controls the pro-
duction of platelets (15). The gene coding for this cytokine
maps to chromosome 3q27–28 and displays a complex pat-
tern of alternative splicing (16–18). Our molecular studies
on the expression of THPO gene have identiﬁed an alterna-
tive spliced isoform corresponding to a mRNA carrying an
insertion of 85 nt generated by the activation of a cryptic
30 splice site within intron 2. We have shown that the
30 end of intron 2 contains G-rich elements that work coordi-
natively mainly for the selection of the authentic 30 splice site
of IVS2. In this work, the heterogeneous ribonucleoprotein
H1 (hnRNP H1) has been identiﬁed as the trans-acting factor
that interacts speciﬁcally with G runs in the THPO context. In
particular, siRNA-mediated down regulation of hnRNP H
indicates that this factor is important to secure the constitu-
tive splicing of intron 2.
MATERIALS AND METHODS
Constructs
The THPO genomic region spanning from exon 1 to exon
4 was ampliﬁed from human genomic DNA in two rounds
to shorten intron 1. In the ﬁrst round, two overlapping PCR
fragments were generated. Fragment A was ampliﬁed using
primer sense Ex1-EcoRV (50-attggatatctgcagaattcgccctttta-30)
and primer antisense (50-cagggtgaacagatgcattctgggaaggctaca-
ctcttctcgaca-30), whereas fragment B was ampliﬁed using
primer IVS1-s (50-tgtcgagaagagtgtagccttcccagaatgcatctgttc-
accctg-30) and Ex4–XhoI (50-acgtctcgagcatctgggttttccattc-
tc-30). In the second round, fragment A and B were used as
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EcoRV and Ex4–XhoI in order to generate the THPO mini-
gene. The PCR product was EcoRV-XhoI cloned in pcDNA
expression vector (Invitrogen) so generating the construct
IVS2-wt (Figure 1c). Subsequently, the constructs carrying
disruption of single or multiple G runs were obtained by
PCR site directed mutagenesis. All constructs were veriﬁed
by sequence analysis using the CEQ 2000 sequencer machine
(Beckman Coulter) to exclude the presence of mutations.
Cell culture and transfections
Human cell lines (HEK-293T, Hep3B and HeLa) were cul-
tured in Dulbecco’s modiﬁed Eagle’s medium with glutamax
(Invitrogen) supplemented with 10% fetal bovine serum and
gentamicin (100 mg/ml). The DNA used for transfections was
puriﬁed with JetStar columns (Genomed). In HEK293 cells,
2 mg of each constructs were transfected with the calcium
phosphate coprecipitation method (19). The total RNA was
extracted using RNAwiz solution (Ambion) and retrotran-
scribed with poly(dT) primer. To amplify only the messen-
gers derived from the transfections, RT–PCR were carried
out using as sense primer, T7 promoter (annealing to the plas-
mid) and the antisense primer speciﬁc for THPO, Ex4–XhoI.
The conditions used for the PCRs were the following: 94 C
for 3 min for the initial denaturation, 94 C for 30 s, 54 C
for 30 s, 72 C for 60 s for 35 cycles and 72 C for 7 min
for the ﬁnal extension. The PCRs were optimized to be in
the exponential phase of ampliﬁcation. The results of all
the transfections are the representative of at least three
independent experiments. The variability among different
experiments was always <20%.
UV-Cross-linking of proteins and RNA
THPO G789 and THPO G789m plasmids were generated by
annealing the oligos THPO G789s (50-ctgaggggtggattccct-
gggtttcaggtctgggtccta-30) and THPO G789as (50-catggag-
gacccagacctgaaacccagggaatccacccctcattcga-30) for the wild
type construct as well as of THPO G789mut-s (50-ctgacgtgt-
ggattccctgagtttcaggtctgagtccta-30) and THPO G789mut-as
(50-catggtaggactcagacctgaaactcagggaatccacacgtcagttcga-30)
for the mutant construct, followed by direct cloning under the
T7 promoter control into KpnI-HindIII digested pBluescript
SK. Plasmids to be transcribed into RNA were ﬁrst linearized
by HindIII digestion. The UV-cross-linking assay was per-
formed by incubation of the [a 
32P]UTP-labeled RNA
probes with 60 mg of HeLa nuclear extracts in 20 mlo f
ﬁnal volume at 30 C for 15 min. Final binding conditions
were 20 mM HEPES, pH 7.9, 72 mM KCl, 1.5 mM
MgCl2, 0.78 mM magnesium acetate, 0.52 mM DTT, 3.8%
glycerol, 0.75 mM ATP, 1 mM GTP and Heparin at a
5 mg/ml ﬁnal concentration as a nonspeciﬁc competitor. In
the competition experiments increasing amounts of cold
RNA (the molar ratios of cold/labeled RNA were 3 and 6)
was also added as a competitor 5 min before addition of
the labeled RNAs. The samples were then transferred in the
wells of an HLA plate (Nunc) and irradiated with UV light
on ice (800 000 kJ for 5 min). Unbound RNA was then
digested with 30 mg of RNase A (Sigma) by incubation
at 37 C for 30 min. The samples were then analyzed by
10% SDS-polyacrylamide gel electrophoresis followed by
autoradiography.
RNA oligos (Proligo) were used to test the binding ability of
G7 run to hnRNP H1. 200 ng of G7wt (50-ucugagggguggau-30)
and G7pyr (50-ucucugggguccau-30 )G 7 m( 5 0-ucugacguguggau-30)
RNAs were labeled by phosphorylation with [g 
32P]ATP
and T4 polynucleotide kinase (New England Biolabs) for 1
ha t3 7  C and 10 ng of each oligo were used for UV-
cross-linking. The gels were dried and exposed to X-OMAT
AR ﬁlms for 1–3 h.
Affinity purification of G789 runs-binding proteins
One nmole ( 8 mg) of cold THPO G789 or G789m RNA was
placed in a 400 ml reaction mixture containing fresh 0.1 M
Sodium Acetate (NaOAc) pH 5.0 and 5 mM sodium
m-periodate (Sigma). Reaction mixtures were incubated for
1 h in the dark at RT. The RNA was ethanol precipitated
and resuspended in 500 ml of 0.1 M NaOAc, pH 5.0. Then,
400 ml of adipic acid dehydrazide agarose bead 50% slurry
(Sigma) were washed four times in 10 ml of 0.1 M NaOAc
pH 5.0 and pelleted after each wash at 3000 r.p.m. for
3 min in a Eppendorf minifuge. After the ﬁnal wash,
300 ml of 0.1 M NaOAc pH 5 were added to the beads.
The slurry was then divided in two aliquots that were
mixed with each periodate-treated RNA sample and incu-
bated over night at 4 C on a rotator. The beads with the
bound RNA were then pelleted and washed three times in
2 ml of 2 M NaCl and three times in 3 ml of RNA wash
buffer (52 mM HEPES-KOH,pH 7.5, 10 mM MgCl2,8m M
Mg(CH3COO)2, 5.2 mM DTT, 38% v/v glycerol). They were
incubated in 1x RNA binding buffer (i.e. RNA wash buffer
added with 7.5 mM ATP, 10 mM GTP and 5 mg/ml Heparin)
with 0.3 mg of HeLa cell nuclear extract for 30 min at RT in
500 ml ﬁnal volume, pelleted by centrifugation at 1000 r.p.m.
for 3 min and washed four times with 1.5 ml of RNA wash
buffer. After the ﬁnal centrifugation 60 ml of SDS–PAGE
sample buffer were added to the beads and heated for
5 min at 90 C before loading on a 10% SDS–PAGE gel.
Internal sequence analysis from the Coomassie stained
bands excised from the SDS–PAGE gel was performed
using an electrospray ionization mass spectrometer (LCQ
DECA XP-ThermoFinnigam). The bands were digested by
trypsin and the resulting peptides were extracted with water
and 60% acetonitrile/1% triﬂuoroacetic acid. The fragments
were then analyzed by mass spectrometry and the proteins
were identiﬁed by analysis of the peptide MS/MS data with
Turbo SEQUEST (ThermoFinnigam) and MASCOT (Matrix
Science).
Small interfering RNA (siRNA) transfections.
siRNA transfections were performed in HeLa cells by using
Oligofectamine Reagent (Invitrogen). One day before siRNA
transfection cells were trypsinized to achieve 40–50% conﬂu-
ency. For a 35 mm-well plate, 2.5 ml of two different siRNA
duplexes (10 mM, Ambion) were mixed with 175 ml of Opti-
MEM medium and, separately, 5 ml Oligofectamine with
15 ml of Opti-MEM medium. The 19 nt-target sequences in
hnRNP H1 were: 50-GGAAATAGCTGAAAAGGCT-30 and
50-CCACGAAAGCTTATGGCCA-30.Thesampleswereincu-
bated for 7 min at room temperature. Then the Oligofectamine
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20 min at room temperature. At the end of this incubation, the
mix was dropped onto the cells maintained in 800 mlo f
Opti-MEM without antibiotics and FCS. After 24 h, a second
siRNA transfection was performed as described above, fol-
lowed by the transfection with the THPO minigenes. The
following day, cells were harvested for RNA extractions,
RT–PCR analyses and western blots. Each transfection experi-
ment was repeated at least three times. The proportion of
hnRNP H1 silencing was quantiﬁed by optical densitometry
using Imagej 1.37 software (http://rsb.info.nih.gov/ij/).
RESULTS
G runs are involved in the control of THPO intron
23 0 splice site selection and exon 2 definition.
RT–PCR analysis of the region spanning exons 1–4 of the
human THPO gene in cell lines that express this cytokine
(human hepatocarcinoma Hep3B and human embryonic
kidney HEK-293T) showed the presence of three PCR prod-
ucts (Figure 1a). Cloning and sequencing of these bands
established that: (i) The band labeled THPO wt, by far the
most abundant PCR product, corresponds to the full length
cDNA encompassing exons 1–4; (ii) the shorter amplicon
labeled THPO-Ex2 represents an alternative splicing isoform
of THPO lacking exon 2; and (iii) the band labeled THPO +
85, the longer PCR product, is another splice variant corre-
sponding to THPO cDNA carrying the inclusion of the
30 end of intron 2. This isoform is the results of the selection
of a cryptic acceptor site placed 85 nt upstream of the authen-
tic 30 splice site.
A search in human expressed sequence tag databases con-
ﬁrmed the presence of +85 THPO mRNA species (Genebank
accession number AB102892). We tried to correlate these
ﬁndings with calculations of the strength of potential splice
sites of exon 2 and 3 in human THPO gene. The analysis
carried out according to the Splice Site Prediction by Neural
Figure 1. Comparison of splicing pattern of endogenous THPO and IVS2-wt construct. (a) Analysis of the exon 1-exon 4 splicing pattern by RT–PCR of
endogenous THPO gene constitutively expressed in Hep3B and HEK293 cell lines. THPOwt is the full length transcript (exon 1+2+3+4). THPO+85 is the full
length transcript including 85 nt from IVS2. THPO-Ex2 is the mRNA excluding exon 2. H2O indicates the PCR control. M indicates the lane with 1 Kb plus DNA
marker. (b) Nucleotide sequence encompassing intron 1-exon 2- intron 2-exon 3 of human THPO gene. Introns are shown in lower case, exons are in bold upper
case. The score of acceptor (a¼) and donor (d¼) splice sites calculated using the Splice Site Prediction by Neural Network program (SSPNN, http://www.fruitfly.
org/seq_tools/splice.html) are indicated. The ten G runs (in uppercase) within intron 2 are numbered 1–10 and the mutagenesis carried out for each G runs is
shown in brackets. An arrow indicates the cryptic 30 splice site within IVS2. (c) Scheme of the human THPO minigene used for transfection experiments. White
boxes correspond to the human THPO exons (Ex) 1–4 and thin lines represent introns (IVS). Sizes of exons and introns are shown. (d) Analysis of pre-mRNA
splicing of IVS2-wt and IVS2-G1-G10m constructs. Amplicons were separated on a 1.3% (w/v) agarose gel.
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splice.html) shows that the authentic acceptor splice site of
IVS2 is weak and its score (0.58) is even lower than that of
the potential acceptor site of IVS2 (0.71) corresponding to the
cryptic 30 splice site activated in the THPO + 85 splice variant
(Figure 1b, arrow). Therefore, the splicing behavior of exon
2 and 3 is not consistent with the in silico analysis. It is there-
fore plausible that accessory cis-acting elements might be
involved in an accurate selection of the authentic acceptor
sites of intron 1 and 2. We have observed that the human
THPO intron 2 contains a high number of guanosine motifs
of lengths ranging from three to ﬁve (Figure 1b, G1–G10).
In order to understand whether the guanosine stretches within
this intron play a role in the control of splicing, we developed
an in vivo minigene system by cloning the genomic region of
the human THPO gene spanning exon 1 to exon 4. (Figure 1c,
IVS2-wt). We then constructed a second minigene where,
through site directed mutagenesis, all the G runs were inter-
rupted by point mutations (IVS-2-G1-10m). Following trans-
fection and expression of the constructs in HEK293 cells,
RT–PCR analysis was performed to determine the splicing
patterns produced by these constructs. Speciﬁc primers
were used for the minigene sequence to differentiate its
product from one derived from the endogenous gene. IVS2-
wt construct predominantly expresses the THPO wt transcript
together with two additional less abundant mRNAs
(Figure 1d, lane 1). Direct sequencing of these puriﬁed
PCR products showed that they correspond to the THPO-
Ex2 and THPO + 85 splice variants previously detected
in vivo. As shown in (Figure 1a and d) the minigene repro-
duces the splicing pattern of the endogenous gene and
hence contains all the necessary information for correct
THPO splicing. The transfection of IVS2-G1-10m minigene
strongly impairs the pre-mRNA processing and changed the
relative proportion of the THPO splicing variants
(Figure 1d, lane 2). The THPO wt isoform was no longer pre-
sent and the predominant PCR products were shown by direct
sequencing to correspond to the THPO+85 splice variant.
Additionally, a novel splicing isoform containing the 85 nt
inclusion and excluding totally exon 2 was also detected
(THPO+85-Ex 2 variant). Therefore, it can be concluded
that the guanosine rich elements within intron 2 can control
both the selection of its 30 splice site and exon 2 deﬁnition.
Mapping of the G motifs-splicing control
elements within THPO intron 2
To determine the contribution of different G runs inthe control
ofintron2splicing,wegeneratedaseriesofIVS2-wtminigene
mutants where G runs were progressively disrupted by point
mutation starting from the 50 end of intron 2 (Figure 2a).
After transfection in HEK293 cells, we observed that the
THPO+85 splice variant was present in a low but increasing
amount, following the disruption of the ﬁrst six G runs
(Figure 2b, lanes 1–4). The strongest effect was observed
when we extended the mutagenesis to the G7 run (Figure 2b,
lane 5), which resulted in a similar splicing pattern to that
obtained with the minigene carrying all G runs mutated
(Figure 2b, lane 6) Thus, the G7 run represents a critical
element for the control of intron 2 splicing.
Other ﬁve variants of the IVS2 construct were generated
where G runs were disrupted by point mutation starting
from the 30 end of intron 2 (Figure 2c). The THPO+85
splicing isoform was predominant over the wild type species
only when G8+G9+G10 elements were mutated at one time
(Figure 2d, lane 5). Moreover, a progressively increasing
Figure 2. Mapping of the G runs splicing control elements within THPO IVS2. (a) and (c) Schemes of the constructs used for transient transfections. The
presence of G runs is indicated by its position-number. (b) and (d) Splicing pattern analyses of the RT–PCR products derived from cellular RNA, separated on a
1.3% agarose gel and stained by ethidium bromide. THPOwt is the full length transcript (exon 1+2+3+4). THPO+85 is the full length transcript including 85 nt
from IVS2. THPO-Ex2 is the mRNA excluding exon 2. THPO+85-Ex2 indicates the mRNA species carrying the 85 nt inclusion along with exon 2 skipping.
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transfections of IVS2-G8-10m, IVS2-G7-10m and IVS2-G1-
10m constructs (Figure 2d, lanes 5–7, respectively). These
results imply that multiple G runs must be present to support
the correct intron 2 removal and an efﬁcient exon 2 splicing.
Coordinate action of different G runs influences
the selection of the 30 splice site within IVS2
The contribution of the different G runs in intron 2 splicing
was then examined by generating a series of minigenes, in
which through site directed mutagenesis we reintroduced
multiple G elements (G7-G8, G7-G8-G9, G7-G8-G9-G10,
G7-G10, G8-G9, Figure 3a and b). It is of interest to note
that multiple G runs such as G7-G8, G7-G8-G9 and
G7-G8-G9-G10 elements caused a signiﬁcant and progressive
increase in the selection of the authentic 30 acceptor site as
compared with the effects of IVS2-G1-10m transfections
(Figure 3c, see lanes 2 to 4). On the other hand, the minigene
carrying only G8 and G9 was not sufﬁcient to shift splicing
towards the authentic 30 acceptor site whereas the construct
with only G7 and G10 was able to rescue the wild type
30 splice site selection just partially (Figure 3d). These results
suggest that G runs in the range G7-G10 work coordinatively
to inﬂuence the splicing of intron 2. The presence of at least
G7,G8 and G9 is therefore necessary for the recognition of
the proper 30 splice site of THPO intron 2 and in the efﬁcient
inclusion of exon 2.
Role of G7 run in the 30 splice site
selection within intron 2
Taking into consideration the apparently central role of the
G7 run in intron 2 splicing, we were interested to test whether
the nucleotides ﬂanking that G stretch could also be involved
in the modulation of the IVS2 splicing. The G7 run is made of
four Gs and surrounded by purine rich nucleotide sequences,
as opposed to G8 and G9 runs, that contain three Gs and are
ﬂanked by pyrimidine rich sequences. This prompted us to
construct a ﬁrst mutant where using the IVS2-G7-G8-G9 tem-
plate, G7 run was reduced from four to three Gs (IVS2-G7g3-
G8G9) and a second variant where the purines immediately
adjacent to G7 were replaced by pyrimidines (IVS2-G7pyr-
G8G9, Figure 4a) . We found that the deletion of one G in
the G7 run strongly increased the THPO+85 isoform
(Figure 4b, lane 2) and the transfection of the IVS2-G7pyr-
G8G9 minigene shifted the splicing pattern toward the com-
plete selection of the isoform that retain the last 85 nt of the
intron 2 (Figure 4b, lane 3). Overall, these experiments indi-
cate that the number of guanosines within G7 as well as the
purines immediately adjacent to this G run are critical for the
correct processing of this intron.
We then conﬁrmed the relevance of G7 for IVS2 splicing
also when the other nine G runs are intact. In fact, we gener-
ated and transfected two mutants of IVS2-wt construct where
the G7 was disrupted at the level of the G-core (IVS2-wt-
G7m, Figure 4a) or of its ﬂanking nucleotides (IVS2-wt-
G7pyr, Figure 4a). The relevance of the G-core was
conﬁrmed since its mutation resulted in the expression of
equal amounts of the THPO+85 as well as of the THPOwt
variants (Figure 4c, lane 2). Surprisingly, the mutation of
the nucleotides ﬂanking G7 did not produce a dramatic
change in the IVS2 splicing pattern (Figure 4c, lane 3). The
latter result suggested that the nucleotides adjacent to G7 can
modulate the 30 splice site selection within IVS2 only when
the surrounding G runs context is weakened. In fact, the
reintroduction of an intact G6 run in the IVS2-G7pyr-G8G9
Figure 3. Effects of combined G7, G8 and G9 runs on THPO splicing. (a) and (b) Schemes of the constructs used for transient transfections. The presence of G
runs is indicated by its position-number. (c) and (d) Splicing pattern analyses of the RT–PCR products derived from cellular RNA, separated on a 1.3% agarose
gel and stained by ethidium bromide.
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signiﬁcant rescue of the THPOwt isoform (Figure 4d, lane 1).
hnRNP H1 binds the G runs critical for
THPO intron 2 splicing
In order to identify the trans-acting factors able to bind the
G runs in the THPO context, UV-cross-linking assays were
performed with in vitro transcribed RNAs containing either
the G7-G8-G9 region of the THPO intron 2 (Figure 5a,
THPO789 construct) or the same sequence carrying point
mutations within the G runs (Figure 5a, THPO789m con-
struct). Figure 5b shows that a 58 kDa protein interacts spe-
ciﬁcally with THPO789 RNA and was no longer present
when THPO789m RNA was used. Competition experiments
then conﬁrmed the binding speciﬁcity. As expected, the
58 kDa protein was rapidly competed away from labeled
THPO789 RNA sequence by the addition of an increasing
amount of cold THPO789 RNA but not by the addition of
an increasing amount of cold THPO789m RNA (Figure 5c).
Next, we used an RNA-afﬁnity puriﬁcation procedure fol-
lowed by mass spectrometry sequencing to identify the G
runs-binding proteins. After incubation of RNA-beads prepa-
rations with HeLa nuclear extract, the RNA protein com-
plexes formed were pulled down and the proteins present in
the complexes fractionated on an SDS–PAGE gel and then
visualized by Coomassie Blue staining (Figure 5d). The
THPO789 RNA speciﬁcally pulled down a 58 kDa protein,
whose molecular weight was similar to that of the band
observed in UV-cross-linking assays. Moreover, three less
abundant proteins of apparent 53 kDa, 38 kDa and 34 kDa
molecular weight were also speciﬁcally pulled down. Internal
sequence analysis by mass spectrometry of the excised
58 kDa band, yielded seven peptides whose sequences belong
to hnRNP H1. The less abundant proteins were also
sequenced and were found to correspond to hnRNP F
(53 kDa) and to two hnRNP H3 isoforms (38 kDa and
34 kDa). These results are consistent with previous studies
showing that members of the hnRNP H family have binding
speciﬁcity for RNA sequences enriched in guanosine (20).
In consideration of the peculiar functional role of the G7
run, we then asked which is the speciﬁc contribution of this
G run to the interaction with hnRNP H1. We evaluated the
ability of RNA oligos spanning only G7 run to bind hnRNP
H1. Therefore, we compared the binding capacity of G7 wild
type (G7wt) sequence to those of G7 with G-core disrupted
(G7m) and of G7 with its ﬂanking purines mutagenized to
pyrimidines (G7pyr). We found a consistent reduction in
hnRNP H1-binding with G7pyr RNA, whereas it is com-
pletely abolished with G7m oligo (Figure 5e). Thus, there
is a good correlation between the ability of G7 element to
bind hnRNP H1 and the in vivo effects of its mutagenesis.
RNAi against hnRNP H promotes activation of the
cryptic acceptor site within THPO intron 2
To obtain more direct evidence for the role of hnRNP H in
splicing of human THPO mRNA, we performed siRNA
experiments against endogenous hnRNP H1 protein. HeLa
cells were used because they were transfected more efﬁ-
ciently with siRNA. The THPO constructs IVS2 G7G8G9
and IVS2-G1-6m were co-transfected after the last round of
Figure 4. Role of G7 run and its flanked nucleotides in the 30 splice site selection within IVS2. (a) Scheme of the constructs used for transient transfections. (b)
RT–PCR of the constructs carrying G7-G8-G9 carrying the reduction from 4 to 3 G in the G7 element and with the flanked nucleotides mutated are indicated with
G7g3 and G7pyr, respectively. (c) RT–PCR products derived from the constructs where the G7 was disrupted at the level of the G-core (IVS-wt-G7m) or in its
flanking nucleotides (IVSwt-G7pyr). (d) The construct IVS2-G6-G7pyr-G8G9 shows a significant rescue of the THPOwt isoform (lane 1).
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endogenous hnRNP H1 by western blot analysis using anti-
H1 rabbit serum. We observed a strong reduction in the
hnRNP H expression in cells transfected with hnRNP H1-
siRNA but not in untransfected cells or in cells treated with
an unrelated siRNA. The expression level of two
housekeeping genes (b-actin and a-tubulin) was unaffected
(Figure 6a). To determine whether the knock-down of
hnRNP H1 has a function in the splicing of the second intron
of THPO gene, RT–PCR assays for THPO mRNA obtained
from the constructs were carried out. SiRNA-mediated
down regulation of hnRNP H promoted a strong increase of
the THPO+85 transcript when the constructs IVS2 G7G8G9
and IVS2-G1-6m were used (Figure 6b). These results indi-
cate that the reduction in the expression of cellular hnRNP
H1 promotes a signiﬁcant but not yet complete usage of the
 85 nt cryptic acceptor site of THPO intron 2. To conﬁrm the
critical role of G7 element also in the IVS2 wild type context
, RNAi experiments against hnRNP H1 were repeated with
cotransfection of the IVS2-wt-G7m minigene. The
THPO+85 isoform became predominant following transient
knock-down of hnRNP H1. This experiment conﬁrmed the
key role of the interaction of hnRNP H1 to G runs probably
primed by the G7 element.
Transfections of the IVS2-wt minigene in siRNA-H1-
treatedHeLacellsandRT–PCRassaysspeciﬁc forthe plasmid
conﬁrmed the increment of the THPO+85 transcript, although
to a lesser extent in comparison with that obtained with IVS2
G7G8G9 and IVS2-G1-6m minigenes (Figure 6d, compare
lanes 1 and 2). Altogether these results indicate that G7-G8-
G9-G10 runs represent the core elements whose interaction
with hnRNP H1 control the selection of the authentic acceptor
splice site of THPO IVS2.
DISCUSSION
In this work, we have characterized the molecular mechanisms
underlying the alternative splicing of THPO intron 2 that
arises from the activation of a cryptic 30 splice site 85 nt
upstream of the authentic 30 splice site. Our interest was
aimed at identifying possible cis-acting elements in THPO
intron 2 able to inﬂuence its processing. We focused on the
peculiar G run cluster present in this short intron as intronic
G runs have been shown to be involved in modulating splic-
ing of several genes in different species (7,11,12,21,22). Our
resultsoverlaponlypartiallywithpreviousstudiesthatdemon-
strated how G runs can enforce weak 30 splice sites. In fact, the
mechanism by which G runs control the splicing and the pro-
cessing efﬁciency of THPO IVS2 seems to be different from
that found in other models. In a-globin intron 2, G triplets
have been shown to act additively both to enhance splicing
and to facilitate exon-intron border recognition (7). Consis-
tently with this model, in IVSB7 of chicken b-tropomyosin,
Figure 5. Interaction of nuclear proteins with G runs within THPO IVS2. (a) Sequence of oligos KpnI/Hind III cloned in pBS KS under T7 promoter control for
in vitro transcription. G7, G8 and G9 runs are in uppercase and the position of G mutagenized by point mutations are indicated with a vertical line. (b) UV-cross-
linking assay using HeLa nuclear extract with in vitro transcribed THPO789 and THPO789m RNAs. The arrow shows the position of the 58 kDa complex.
(c) Competition analysis confirms the binding specificity of the 58 kDa complex following addition of cold THPO789 and THPO789m RNAs to labeled
THPO789 RNA in the presence of HeLa nuclear extract. The molar ratio of cold/labeled RNA was three and six. The arrows indicate the 58 kDa complex.
(d) Coomassie stained SDS–PAGE of a pull-down assay using adipic dehydrazide beads derivatized with the RNAs following incubation with HeLa nuclear
extract. In the lane from the wild type RNA-derivatized beads (THPO789), the arrows indicate the proteins that are present only in the wild type THPO789 RNA-
derivatized beads. (e) UV-cross-linking assay using HeLa nuclear extract with RNA oligos spanning only wild type G7 run (G7wt), G7 with its flanking
nucleotides mutagenized (G7pyr) and of G7 with G-core disrupted (G7m). The arrow shows the position of the hnRNP H1 proteins.
138 Nucleic Acids Research, 2007, Vol. 35, No. 1six (A/UGGG) repeats had an additive effect and were essen-
tial for spliceosome assembly (5). In the apoptotic Bcl-x
gene, a cis-acting element with two G runs was shown to
enhance the 50 splice site of Bcl-xs (13). Conversely, in
the CI cassette exon (exon 19) of the glutamate NMDA
R1 receptor, a 50 splice site proximal GGGG motif was
shown to work in combination and cooperatively with a dif-
ferent element (an exonic UAGG sequence) to silence CI
exon (8). Finally, in the 844ins68 allele of the CBS gene
there is a duplication of the 30 splice site at the CBS intron7/
exon8 junction and G runs in between the two identical
splice sites were shown to promote the selection of the distal
one (11). In the THPO gene, in vivo experiments show
that intronic G motifs affect splicing through a complex
combinatorial mechanism derived by different actions of
the G7, G8, G9 and G10 motifs. Splice site recognition
depends on coordinate action of different cis-acting elements
and our in vivo results show that G runs in the G7-G10
range are not simply a redundant back-up system for splic-
ing ﬁdelity.
In silico and in vivo results suggest that there is a competi-
tion among the two ‘weak’ authentic 30 splice sites of exon
2-exon 3 and the ‘strong’ cryptic 30 splice site within intron
2. In particular, the observation that G8+G9 runs alone are
not able to inhibit the cryptic 30 splice site is compatible
with an enhancing role of these elements of the authentic
30 splice site. On the other hand, the data showing that an
increasing number of G runs in IVS2 is associated with a
higher proportion of wild type transcripts lets us speculate
that the higher number of G runs might stabilize the interac-
tion with hnRNP H1 and consequently block the access to the
cryptic 30 splice site by steric hindrance.
The G7 run is the splicing hub of intron 2: its presence is
determinant to secure the constitutive processing of intron
2 as demonstrated by the results of siRNA-H1 assays with
IVS2-wt-G7m and by the fact that the control the 30 splice
site selection is determined by the G-core as well as the
ﬂanking nucleotides of this element. This latter observation re-
presentsanimportantcorollaryofthesedatabecauseitdemon-
strates that the effects of G runs on splicing can be further
modulated by the nucleotides surrounding the G cores. Inves-
tigations into the proteins interacting with G runs in THPO
IVS2 context have shown that RNA containing G7-G8-G9
motifs bind mainly hnRNP H1, and other members of
Figure 6. Knock-down of hnRNPH1 causes the activation of the cryptic acceptor site within IVS2. (a) Western blot carried out with polyclonal anti-hnRNP H1
antiserum on HeLa cell non transfected (NT HeLa cells) or transfected with siRNA against hnRNP H1 (siRNA-H1) or luciferase (siRNA-luc). b-tubulin and
a-actin were probed with polyclonal antibodies as a control of total protein loading. Relative amounts of hnRNP H1 silencing are indicated below each lane.
Standard deviations were always <20%. (b) The panel shows splicing pattern analysis of RT–PCR products after cotransfection of IVS2 G7G8G9 and IVS2-G1-
6m along with either the siRNA-H1 (lanes 2 and 4 ) or a control siRNA-luc oligonucleotides (lanes 1 and 3). (c) RT–PCR experiments after RNAi against hnRNP
H1 and cotransfection with the IVS2-wt-G7m minigene. Lane 1 shows the cotransfection of IVS-wt-G7m with a control siRNA. After siRNA anti-hnRNP H the
THPO+85 isoform became predominant (lane 2). Lower panels show the related anti-hnRNP H1 western blot analyses .b-tubulin was used as a control of total
protein loading. Relative amount of hnRNP H1 silencing is indicated below each lane. Standard deviation were <20%. (d) RT–PCR experiments in siRNA-H1-
treated in HeLa cells. Lanes 1 and 2 show the results of PCR after cotransfecting the IVS2-wt minigene. After the reduction in the expression of hnRNP H there is
a small increase of the THPO+85 isoform. The control transfection was loaded in lane 1. Lower panels show the related anti-hnRNP H1 western blot analyses
with indication of relative amounts of hnRNP H1 silencing. Standard deviations were <20%.
Nucleic Acids Research, 2007, Vol. 35, No. 1 139hnRNP H family (hnRNP F and hnRNP H3), but to a lesser
extent. The co-puriﬁcation by RNA-afﬁnity of hnRNP F
together with hnRNP H1 is consistent with previous work
showing that both hnRNP H and hnRNP F bind to poly(G)
sequences (23) and can form heterodimers (24). Other studies
have reported the involvement of hnRNP H1 in the splicing of
different genes with silencing or enhancing effects depending
on its interaction with exonic (11,25–28) or intronic (24)
sequences, respectively. Apparently, the G7 run might have
more afﬁnity for hnRNP H1 because it is the only element
(among the last four) that contains four Gs instead of three.
Therefore, it is possible that the interaction of hnRNP H1
with the G7 run might strengthen in vivo the interaction of
this trans-acting factor onto the downstream G elements.
These data support the hypothesis that the stable interaction
of hnRNP H1 with the last four G runs favors the constitutive
splicing of intron 2.
On the other hand, the ﬁnding that the IVS2-wt-G7m con-
struct is still responsive to siRNA-H1 assays whereas the
IVS2-wt construct is less sensitive gives a hint onto the pos-
sible involvement of further elements in the THPO IVS2
splicing. From our experiments, it is apparent that accessory
components are involved in the modulation of THPO IVS2.
Intriguingly, intronic G runs within THPO IVS2 might play
a structural role, e.g. as previously shown for G quartets in
fragile X retardation (29). Alternatively, they might enroll
additional proteins such as other members of the hnRNP H
family that could exhibit redundant activity with hnRNP
H1. The recruitment of these factors might be favored by
the RNAi-mediated depletion of hnRNP H1 and seems to
be effective only in the presence of intact G runs. In fact, it
is sufﬁcient for the mutagenization of G7 to weaken the
G-runs-framework and to make inefﬁcient the complementa-
tion of hnRNP H1. This ﬁnding is consistent with the ability
of G runs to work cooperatively (7) similarly to what already
documented for hnRNP A1 (30–32). Therefore, we have
demonstrated that the G7 run has a pivotal role over the
last four G runs for the control of IVS2 splicing through inter-
action with hnRNP H1, but more complex mechanisms may
be involved. Future studies will be required to establish
whether accessory elements are involved.
Finally, we should consider what could be the reason for
such a complex control of the alternative splicing of both
THPO intron 2 and exon 2 other than a bad evolutionary
‘joke’. Several studies have proven the relevance of alterna-
tive splicing in the regulation of translational efﬁciency of
different protein involved both in physiological (18,33–35)
and pathological events (36–39). In particular, a recent report
has shown that a mRNA isoform generated by alternative
splicing affects the composition of the 50 end of THPO and
may be an additional control mechanism for its produc-
tion (18). The insertion of 85 nt in the novel THPO+85
splicing variant should produce a shift in the reading frame
after codon 4 with the generation of a THPO precursor
Figure 7. Evolutionary comparison of the splicing control elements found in THPO intron 2 in human, macaca, chimpanzee, dog, mouse and rat. (a) The
alignment of intron 2 from different species was generated using the GeneBee method (http://www.genebee.msu.ru/genebee.html). All G runs in human intron
2 are underlined. The human cryptic 30 splice site between G8 and G9 runs is boxed. (b) Graphical phylogenetic tree generated by the GeneBee server that
depicts the distances among different species for THPO IVS2.
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acids and a premature stop codon after codon 56. Interest-
ingly, a phylogenetic analysis of THPO IVS2 shows that,
on one hand, the composition of  85 cryptic acceptor site
and of its ﬂanking nucleotides is substantially conserved in
different species such as dog, mouse and rat but not in
other primates. On the other hand, the distribution of G
runs and, in particular, the presence of those corresponding
to human G7, G8 and G9 is not likewise conserved
(Figure 7). Intriguingly, the comparison of THPO IVS2 in
primates outlines that the  85 cryptic acceptor site is present
neither in Pan troglodytes or in Macaca mulatta because it is
disrupted by a A->G substitution that creates a new G run.
Therefore, if the alternative splicing of IVS2 controlled by
G runs is involved in regulation of THPO expression, its
modulation in human might occur in different way in com-
parison not only with distant but also with closely related spe-
cies. In conclusion, the peculiar role of the IVS2 G runs in
human might be part of the circuit that control the expression
of the THPO protein.
ACKNOWLEDGEMENTS
The authors wish to thank Dr Emanuele Buratti for helpful
suggestions and comments, and Ms Anna Meneghello for
technical support. This work was supported by grants from
Telethon Onlus Foundation–Italy (n. GGP02453) and EU
FPVI (LSHG-CT-2005-518238) to F.E.B. Funding to pay the
Open Access publication charges for this article was provided
by ICGEB Institutional funding.
Conflict of interest statement. None declared.
REFERENCES
1. Black,D.L. (2003) Mechanisms of alternative pre-messenger RNA
splicing. Annu. Rev. Biochem., 72, 291–336.
2. Nussinov,R. (1987) (A)GGG(A), (A)CCC(A) and other potential
30 splice signals in primate nuclear pre-mRNA sequences. Biochim.
Biophys. Acta., 910, 261–270.
3. Nussinov,R. (1988) Conserved quartets near 50 intron junctions in
primate nuclear pre-mRNA. J. Theor. Biol., 133, 73–84.
4. Nussinov,R. (1989) Conserved signals around the 50 splice sites in
eukaryotic nuclear precursor mRNAs: G-runs are frequent in the
introns and C in the exons near both 50 and 30 splice sites. J. Biomol.
Struct. Dyn., 6, 985–1000.
5. Sirand-Pugnet,P., Durosay,P., Brody,E. and Marie,J. (1995) An intronic
(A/U)GGG repeat enhances the splicing of an alternative intron of the
chicken beta-tropomyosin pre-mRNA. Nucleic Acids Res., 23,
3501–3507.
6. Carlo,T., Sterner,D.A. and Berget,S.M. (1996) An intron splicing
enhancer containing a G-rich repeat facilitates inclusion of a vertebrate
micro-exon. Rna, 2, 342–353.
7. McCullough,A.J. and Berget,S.M. (1997) G triplets located throughout
a class of small vertebrate introns enforce intron borders and regulate
splice site selection. Mol. Cell Biol., 17, 4562–4571.
8. Han,K., Yeo,G., An,P., Burge,C.B. and Grabowski,P.J. (2005) A
combinatorial code for splicing silencing: UAGG and GGGG motifs.
PLoS Biol., 3, e158.
9. Cogan,J.D., Prince,M.A., Lekhakula,S., Bundey,S., Futrakul,A.,
McCarthy,E.M. and Phillips,J.A., 3rd (1997) A novel mechanism of
aberrant pre-mRNA splicing in humans. Hum. Mol. Genet, 6, 909–912.
10. McCarthy,E.M. and Phillips,J.A., 3rd (1998) Characterization of an
intron splice enhancer that regulates alternative splicing of human GH
pre-mRNA. Hum. Mol. Genet, 7, 1491–1496.
11. Romano,M., Marcucci,R., Buratti,E., Ayala,Y.M., Sebastio,G. and
Baralle,F.E. (2002) Regulation of 3’ splice site selection in the
844ins68 polymorphism of the cystathionine b-synthase gene. J. Biol.
Chem., 12, 12.
12. Mine,M., Brivet,M., Touati,G., Grabowski,P., Abitbol,M. and
Marsac,C. (2003) Splicing error in E1alpha pyruvate dehydrogenase
mRNA caused by novel intronic mutation responsible for lactic
acidosis and mental retardation. J. Biol. Chem., 278, 11768–11772.
13. Garneau,D., Revil,T., Fisette,J.F. and Chabot,B. (2005) Heterogeneous
Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative
Splicing of the Apoptotic Mediator Bcl-x. J. Biol. Chem., 280,
22641–22650.
14. Grabowski,P.J. (2004) A molecular code for splicing silencing:
configurations of guanosine-rich motifs. Biochem. Soc. Trans., 32,
924–927.
15. Kaushansky,K. (1997) Thrombopoietin: understanding and
manipulating platelet production. Annu. Rev. Med., 48, 1–11.
16. Gurney,A.L., Kuang,W.J., Xie,M.H., Malloy,B.E., Eaton,D.L. and de
Sauvage,F.J. (1995) Genomic structure, chromosomal localization, and
conserved alternative splice forms of thrombopoietin. Blood, 85,
981–988.
17. Li,B., Pan,H., Winkelmann,J.C. and Dai,W. (1996) Thrombopoietin
and its alternatively spliced form are expressed in human amygdala and
hippocampus. Blood, 87, 5382–5384.
18. Ghilardi,N., Wiestner,A. and Skoda,R.C. (1998) Thrombopoietin
production is inhibited by a translational mechanism. Blood, 92,
4023–4030.
19. Ausubel,F.M., Brent,R., Kingston,R.E., Moore,D.D., Seidman,J.G.,
Smith,J.A. and Struhl,K. (1992) Short Protocols in Molecular Biology.
Greene Publishing Associates, New York.
20. Caputi,M. and Zahler,A.M. (2001) Determination of the RNA binding
specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP)
H/H’/F/2H9 family. J. Biol. Chem., 276, 43850–43859.
21. Expert-Bezancon,A., Sureau,A., Durosay,P., Salesse,R.,
Groeneveld,H., Lecaer,J.P. and Marie,J. (2004) hnRNP A1 and the SR
proteins ASF/SF2 and SC35 have antagonistic functions in splicing of
beta-tropomyosin exon 6B. J. Biol. Chem., 279, 38249–38259.
22. Yeo,G., Hoon,S., Venkatesh,B. and Burge,C.B. (2004) Variation in
sequence and organization of splicing regulatory elements in vertebrate
genes. Proc. Natl Acad Sci. USA, 101, 15700–15705.
23. Matunis,M.J., Xing,J. and Dreyfuss,G. (1994) The hnRNP F protein:
unique primary structure, nucleic acid-binding properties, and
subcellular localization. Nucleic Acids Res., 22, 1059–1067.
24. Chou,M.Y., Rooke,N., Turck,C.W. and Black,D.L. (1999) hnRNP H is
a component of a splicing enhancer complex that activates a c-src
alternative exon in neuronal cells. Mol. Cell Biol., 19, 69–77.
25. Chen,C.D., Kobayashi,R. and Helfman,D.M. (1999) Binding of
hnRNP H to an exonic splicing silencer is involved in the regulation
of alternative splicing of the rat beta-tropomyosin gene. Genes Dev.,
13, 593–606.
26. Jacquenet,S., Mereau,A., Bilodeau,P.S., Damier,L., Stoltzfus,C.M. and
Branlant,C. (2001) A second exon splicing silencer within human
immunodeficiency virus type 1 tat exon 2 represses splicing of Tat
mRNA and binds protein hnRNP H. J. Biol. Chem., 276, 40464–40475.
27. Pagani,F., Buratti,E., Stuani,C. and Baralle,F.E. (2003) Missense,
nonsense, and neutral mutations define juxtaposed regulatory elements
of splicing in cystic fibrosis transmembrane regulator exon 9. J. Biol.
Chem., 278, 26580–26588.
28. Buratti,E., Baralle,M., De Conti,L., Baralle,D., Romano,M.,
Ayala,Y.M. and Baralle,F.E. (2004) hnRNP H binding at the 50 splice
site correlates with the pathological effect of two intronic mutations in
the NF-1 and TSHbeta genes. Nucleic Acids Res., 32, 4224–4236.
29. Darnell,J.C., Jensen,K.B., Jin,P., Brown,V., Warren,S.T. and
Darnell,R.B. (2001) Fragile X mental retardation protein targets G
quartet mRNAs important for neuronal function. Cell, 107, 489–499.
30. Damgaard,C.K., Tange,T.O. and Kjems,J. (2002) hnRNP A1 controls
HIV-1 mRNA splicing through cooperative binding to intron and exon
splicing silencers in the context of a conserved secondary structure.
Rna, 8, 1401–1415.
31. Stoltzfus,C.M. and Madsen,J.M. (2006) Role of viral splicing elements
and cellular RNA binding proteins in regulation of HIV-1 alternative
RNA splicing. Curr. HIV Res., 4, 43–55.
32. Zhu,J., Mayeda,A. and Krainer,A.R. (2001) Exon identity established
through differential antagonism between exonic splicing
silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol. Cell,
8, 1351–1361.
Nucleic Acids Research, 2007, Vol. 35, No. 1 14133. Nishimura,H., Washizu,J., Nakamura,N., Enomoto,A. and Yoshikai,Y.
(1998) Translational efficiency is up-regulated by alternative exon in
murine IL-15 mRNA. J. Immunol., 160, 936–942.
34. Arora,S. and Chauhan,S.S. (2002) Identification and characterization of
a novel human cathepsin L splice variant. Gene, 293, 123–131.
35. Shalev,A., Blair,P.J., Hoffmann,S.C., Hirshberg,B., Peculis,B.A. and
Harlan,D.M. (2002) A proinsulin gene splice variant with increased
translation efficiency is expressed in human pancreatic islets.
Endocrinology, 143, 2541–2547.
36. Konig,H., Ponta,H. and Herrlich,P. (1998) Coupling of signal
transduction to alternative pre-mRNA splicing by a composite splice
regulator. Embo J., 17, 2904–2913.
37. Zwicky,R., Muntener,K., Csucs,G., Goldring,M.B. and Baici,A.
(2003) Exploring the role of 50 alternative splicing and of the
3’-untranslated region of cathepsin B mRNA. Biol. Chem., 384,
1007–1018.
38. Minn,A.H., Kayton,M., Lorang,D., Hoffmann,S.C., Harlan,D.M.,
Libutti,S.K. and Shalev,A. (2004) Insulinomas and expression of an
insulin splice variant. Lancet, 363, 363–367.
39. Boissel,J.P., Zelenka,M., Godtel-Armbrust,U., Feuerstein,T.J. and
Forstermann,U. (2003) Transcription of different exons 1 of the
human neuronal nitric oxide synthase gene is dynamically
regulated in a cell- and stimulus-specific manner. Biol. Chem.,
384, 351–362.
142 Nucleic Acids Research, 2007, Vol. 35, No. 1